NF-κB is activated by proinflammatory factors such as TNF-α and IL-1 and, in the tumor microenvironment, can drive both proinflammatory responses and, under certain conditions, be reprogrammed to support tumor cell survival and proliferation [75]. This evidence concerns the gene NFKB1 and neoplasm.